Apogee secures $1.3 billion financing deal with Blackstone for drug development

May 27, 2026 6:31 AM

Apogee Therapeutics Inc. (NASDAQ: APGE) announced a strategic financing collaboration with Blackstone Life Sciences providing up to $1.3 billion in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found